Pamidronate Attenuates Oxidative Stress and Energetic Metabolism Changes but Worsens Functional Outcomes in Acute Doxorubicin-Induced Cardiotoxicity in Rats
Author(s) -
Paula Bernardo de Carvalho,
Andréa de Freitas Gonçalves,
Patricia Alegre,
Paula S. Azevedo,
Meliza Goi Roscani,
Carolina Marabesi Bergamasco,
Pamela Modesto,
Ana Angélica Henrique Fernandes,
Marcos Ferreira Minicucci,
Sérgio Alberto Rupp de Paiva,
Leonardo Antonio,
Leonardo A. M. Zornoff,
Bertha Furlan Polegato
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000452558
Subject(s) - cardiotoxicity , doxorubicin , medicine , oxidative stress , anthracycline , endocrinology , pharmacology , ejection fraction , heart failure , cardiac function curve , chemotherapy , cancer , breast cancer
Cardiotoxicity is the major side effect of doxorubicin. As mechanisms that are involved in cardiotoxicity are ambiguous, new methods for attenuating cardiotoxicity are needed. Recent studies have shown that bisphosphonates can decrease oxidative stress. Therefore, the objective of this study was to evaluate the effect of pamidronate on preventing acute doxorubicin-induced cardiotoxicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom